Terms: = Liver cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA AND Treatment
6 results:
1. Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract cancers.
Wu CE; Pan YR; Yeh CN; Lunec J
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33113997
[TBL] [Abstract] [Full Text] [Related]
2. Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.
Cole AJ; Dickson KA; Liddle C; Stirzaker C; Shah JS; Clifton-Bligh R; Marsh DJ
Cell Mol Life Sci; 2021 Feb; 78(3):1011-1027. PubMed ID: 32458023
[TBL] [Abstract] [Full Text] [Related]
3. [Mechanism study on anti-proliferative effects of curcumol in human hepatocarcinoma HepG2 cells].
Huang LZ; Wang J; Lu FT; Yang FC; Chen X; Hong X; Jiang XS
Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1812-5. PubMed ID: 24010301
[TBL] [Abstract] [Full Text] [Related]
4. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
Meng XZ; Zheng TS; Chen X; Wang JB; Zhang WH; Pan SH; Jiang HC; Liu LX
J Gastroenterol Hepatol; 2011 Jan; 26(1):186-93. PubMed ID: 21175813
[TBL] [Abstract] [Full Text] [Related]
5. Hepatocellular adenoma: cost-effectiveness of different treatment strategies.
van der Sluis FJ; Bosch JL; Terkivatan T; de Man RA; Ijzermans JN; Hunink MG
Radiology; 2009 Sep; 252(3):737-46. PubMed ID: 19717753
[TBL] [Abstract] [Full Text] [Related]
6. MRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers.
Kanai Y; Ushijima S; Saito Y; Nakanishi Y; Sakamoto M; Hirohashi S
J Cancer Res Clin Oncol; 2001 Dec; 127(12):697-706. PubMed ID: 11768609
[TBL] [Abstract] [Full Text] [Related]
